CN1528360A - 植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用 - Google Patents
植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用 Download PDFInfo
- Publication number
- CN1528360A CN1528360A CNA031340865A CN03134086A CN1528360A CN 1528360 A CN1528360 A CN 1528360A CN A031340865 A CNA031340865 A CN A031340865A CN 03134086 A CN03134086 A CN 03134086A CN 1528360 A CN1528360 A CN 1528360A
- Authority
- CN
- China
- Prior art keywords
- herba menthae
- preparation
- menthae rotundifoliae
- pharyngeal
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 208000006881 esophagitis Diseases 0.000 title claims abstract description 14
- 208000031169 hemorrhagic disease Diseases 0.000 title claims abstract description 14
- 244000078639 Mentha spicata Species 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims abstract description 33
- 239000008187 granular material Substances 0.000 claims abstract description 17
- 239000002775 capsule Substances 0.000 claims abstract description 10
- 238000002347 injection Methods 0.000 claims abstract description 7
- 239000007924 injection Substances 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims description 12
- 210000000214 mouth Anatomy 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000000341 volatile oil Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 4
- 235000019445 benzyl alcohol Nutrition 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 239000004925 Acrylic resin Substances 0.000 claims description 2
- 229920000178 Acrylic resin Polymers 0.000 claims description 2
- 229940046011 buccal tablet Drugs 0.000 claims description 2
- 239000006189 buccal tablet Substances 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000013270 controlled release Methods 0.000 claims description 2
- 230000006837 decompression Effects 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 239000004531 microgranule Substances 0.000 claims description 2
- 239000011859 microparticle Substances 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 238000013268 sustained release Methods 0.000 claims description 2
- 239000012730 sustained-release form Substances 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 9
- 230000036407 pain Effects 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 208000025865 Ulcer Diseases 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 231100000397 ulcer Toxicity 0.000 abstract description 2
- 241001072983 Mentha Species 0.000 abstract 3
- 208000032843 Hemorrhage Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010030216 Oesophagitis Diseases 0.000 abstract 1
- 201000007100 Pharyngitis Diseases 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 208000003265 stomatitis Diseases 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 235000014749 Mentha crispa Nutrition 0.000 description 3
- 244000024873 Mentha crispa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 241000207923 Lamiaceae Species 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000192023 Sarcina Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用。其中所用的留兰香(Mentha spicata L.)为唇形科薄荷属植物。采用留兰香植物的茎叶干品,经提取加工而成,留兰香植物与制剂的重量比为0.5-100∶1。该药物原料来源广泛,制备工艺先进,其消炎、止血、止痛、消除炎性水肿和溃疡等功能突出。其特点是疗程短、见效快、不影响患者工作和休息,且药物属纯天然产物,无毒副作用,成本低,宜于推广应用。该药可根据临床实际需要制成颗粒冲剂、散剂、胶囊制剂、口服剂及注射剂。
Description
技术领域:本发明涉及一种植物留兰香的新药用途,特别是以留兰香为原料制备治疗口腔、咽部、食道炎症及出血病药物方面的应用。
背景技术:留兰香(Mentha spicata L.)为唇形科薄荷属植物,性味辛、甘、微温,具有祛风散寒、理气、止痛、止咳、消肿、解毒之功能。历代本草对留兰香少有记述,偶有提及,如《本草药性备药》中说:“治小儿乳咳”,《岭南采药录》中说“转散风寒调经,治妇人经期腹痛”。一般主治用于感冒、发烧、咳嗽、胃肠胀气、跌打瘀痛、目赤肿痛、鼻出血、乌疔等疾病。目前,国内外尚未把留兰香载入药典,更没有把其作为临床治疗药物使用。
发明内容:本发明的主要目的是提供留兰香(Mentha spicata L.)作为制备治疗口腔、咽部、食道炎症及出血病药物的使用。至今,国内外在治疗口腔、咽部、食道炎症及出血病尚缺乏应用单一天然植物药取得良好药效,并无毒副作用的药物。应用留兰香单一天然植物治疗该病尚属首次。
本发明的目的是通过如下技术方案实现的:所用留兰香(Menthaspicata L.)为唇形科薄荷属植物。采用留兰香植物的茎叶干品,经提取加工而成,留兰香植物与制剂的重量比为0.5-100∶1。其药物可制成下述剂型:
1.制备颗粒冲剂、胶囊、口服液、含片;
2.制备具有控释技术和微粒胶囊技术的制剂;
3.制备成注射型制剂(肌肉或静脉);
留兰香治疗口腔、咽部、食道炎症及出血病的发明,是经沈阳药科大学和辽宁省中药新药研制开发中心进行大量的科学试验,并对其植物中含有的天然药物化学成分进行分析其结果表明:留兰香药效成份不仅存在于其芳香挥发油中,更主要存在于其非挥发性部位中。
经大量的研究工作证明,并首次在国内外发现了留兰香植物含有的五种世界上从未发现的新化合物,如:10,13,14-三羟基-11-(Z)-十八碳烯酸(S8)、留兰香苷A、留兰香苷B。大量实验研究证明,留兰香所含有效成份对所建立的抗菌活性筛选体系中的金黄色葡萄球菌、表皮葡萄球菌、大肠杆菌、蜡样芽胞杆菌、肺炎杆菌、腾黄八叠球菌、绿脓杆菌等菌属具有明显的抑制作用。给大鼠连续三天灌胃留兰香颗粒冲剂2g/kg,可明显抑制角叉菜胶致大鼠足肿胀。用留兰香颗粒冲剂6g/kg连续六天对大鼠灌胃,可明显抑制大鼠慢性肉芽肿形成,其抑制率高达30.2%。用留兰香5g/kg、10g/kg连续灌胃三天,可明显延长小鼠对热板疼痛的痛阈时间,其痛阈延长率高达50.1%、58%。给小鼠连续5天灌胃留兰香颗粒冲剂2.5g/kg、5g/kg、10g/kg,可明显增加小鼠血液内血小板数量。从上述药效试验结果表明留兰香除对急慢性炎症有较强的抑制作用外,还具有止痛和止血作用。留兰香冲剂对小鼠给药进行急性毒性试验表明:小鼠灌胃留兰香冲剂1日内的最大耐受量为168g(生药)/kg,相当于60kg体重人用量的224倍。
该药物原料来源广泛,制备工艺先进,其消炎、止血、止痛、消除炎性水肿和溃疡等功能突出。其特点是疗程短、见效快、不影响患者工作和休息,且药物属纯天然产物,无毒副作用,成本低,宜于推广应用。该药可根据临床实际需要制成颗粒冲剂、散剂、胶囊制剂、口服剂及注射制剂。
具体实施方式:
下面结合实施例对本发明做进一步说明。
实施例一
制备颗粒冲剂
首先净选干品留兰香2000g,加入10倍量的水浸透,用水蒸馏法提取挥发油,提取4小时,收集挥发油,水液另器收集,过滤,滤液在50℃温度下浓缩至相对密度为1.25-1.30的浸膏,药渣用60%乙醇回流提取二次,每次1小时,合并两次提取液,过滤,滤液回收乙醇并在50℃温度下浓缩至相对密度为1.25-1.30的浸膏,合并两次浸膏,然后减压、干燥、粉碎、用乙醇制粒,再干燥、整粒,分装即得成品颗粒冲剂1000g。
实施例二
制备缓释微粒胶囊
处方:留兰香干品2000g,淀粉1000g,乙醇适量。
制法:如颗粒剂中制备方法制得干浸膏粉,加入淀粉1000g混合均匀,用适量乙醇搅拌制粒,干燥,用肠溶性丙烯酸树脂包衣,装入胶囊,共制得胶囊5000粒。
实施例三
制备注射剂(肌肉)
处方:留兰香干品1000g,NaCl8g,苯甲醇10ml,加注射用水至1000ml。
制法:取干品留兰香1000g,加10倍量蒸馏水浸透,用水蒸馏法提取挥发油,收集挥发油,水液另器收集,滤过,滤液浓缩后加入乙醇搅拌,沉淀滤过,滤液回收乙醇,与上述浓缩液合并,滤过,加苯甲醇10ml,加NaCl8g,搅拌溶解,加注射用水至1000ml,G3垂熔玻璃漏斗滤过,灌封,100℃灭菌30min。
Claims (7)
1、植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用,其特征在于:采用留兰香植物的茎叶干品,经提取加工而成,留兰香植物与制剂的重量比为0.5-100∶1。
2、根据权利要求1所述的植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用,其特征在于:可制备颗粒冲剂、胶囊、口服液或含片。
3、根据权利要求1所述的植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用,其特征在于:可制备具有控释技术和微粒胶囊技术的制剂。
4、根据权利要求1所述的植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用,其特征在于:可制备成注射型制剂。
5、根据权利要求2所述的植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用,其特征在于:制备颗粒冲剂,首先净选干品留兰香2000g,加入10倍量的水浸透,用水蒸馏法提取挥发油,提取4小时,收集挥发油,水液另器收集,过滤,滤液在50℃温度下浓缩至相对密度为1.25-1.30的浸膏,药渣用60%乙醇回流提取二次,每次1小时,合并两次提取液,过滤,滤液回收乙醇并在50℃温度下浓缩至相对密度为1.25-1.30的浸膏,合并两次浸膏,然后减压、干燥、粉碎、用乙醇制粒,再干燥、整粒,分装即得成品颗粒冲剂1000g。
6、根据权利要求3所述的植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用,其特征在于:制备缓释微粒胶囊,处方:留兰香干品2000g,淀粉1000g,乙醇适量;制法:如颗粒剂中制备方法制得干浸膏粉,加入淀粉1000g混合均匀,用适量乙醇搅拌制粒,干燥,用肠溶性丙烯酸树脂包衣,装入胶囊,共制得胶囊5000粒。
7、根据权利要求4所述的植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用,其特征在于:制备注射剂,处方:留兰香干品1000g,NaCl8g,苯甲醇10ml,加注射用水至1000ml;制法:取干品留兰香1000g,加10倍量蒸馏水浸透,用水蒸馏法提取挥发油,收集挥发油,水液另器收集,滤过,滤液浓缩后加入乙醇搅拌,沉淀滤过,滤液回收乙醇,与上述浓缩液合并,滤过,加苯甲醇10ml,加NaCl8g,搅拌溶解,加注射用水至1000ml,G3垂熔玻璃漏斗滤过,灌封,100℃灭菌30min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA031340865A CN1528360A (zh) | 2003-09-28 | 2003-09-28 | 植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA031340865A CN1528360A (zh) | 2003-09-28 | 2003-09-28 | 植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1528360A true CN1528360A (zh) | 2004-09-15 |
Family
ID=34286130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA031340865A Pending CN1528360A (zh) | 2003-09-28 | 2003-09-28 | 植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1528360A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100516186C (zh) * | 2006-05-12 | 2009-07-22 | 魏平飞 | 从春兰花中提取的呈香组合物及其提取方法 |
-
2003
- 2003-09-28 CN CNA031340865A patent/CN1528360A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100516186C (zh) * | 2006-05-12 | 2009-07-22 | 魏平飞 | 从春兰花中提取的呈香组合物及其提取方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1079152A (zh) | 一种速效骨伤灵的制备方法 | |
CN102228485A (zh) | 用于烧伤康复的组合物及其制备方法 | |
CN103990028A (zh) | 中药痱子粉 | |
CN1589852A (zh) | 治疗感冒的外用滴鼻剂及制备方法 | |
CN1528360A (zh) | 植物留兰香作为制备治疗口腔、咽部、食道炎症及出血病药物的应用 | |
CN100411666C (zh) | 用于治疗蛇伤、及蜂、蜈蚣、毒虫咬伤和痈、疽、疖的药物组合物 | |
CN103446564B (zh) | 一种抗菌消炎的中药组合物及其制备方法 | |
CN104138348A (zh) | 一种促微循环美白抑菌面膜的制备 | |
CN1528358A (zh) | 植物留兰香作为制备治疗泌尿系统炎症及出血病药物的应用 | |
CN1528357A (zh) | 植物留兰香作为制备治疗“噎嗝”病药物的应用 | |
CN1528356A (zh) | 植物留兰香作为制备治疗妇科炎症及出血疾病药物的应用 | |
CN1528361A (zh) | 植物留兰香作为制备治疗上呼吸道系统炎症及出血病药物的应用 | |
CN1528359A (zh) | 植物留兰香作为制备治疗慢性胃炎、胃、十二指肠溃疡及出血病药物的应用 | |
CN102688368B (zh) | 一种用于治疗外伤止血或顽固性溃疡的中药 | |
CN1159042C (zh) | 一种留兰香制备治疗慢性及溃疡性结肠炎药物的应用 | |
CN101703570A (zh) | 一种应用植物留兰香制备治疗萎缩性胃炎药物 | |
CN101214280B (zh) | 一种治疗烧伤创疡的中药及其制备方法 | |
CN112022947A (zh) | 基于传统中草药及小分子化合物的抑菌剂及其制备方法和应用 | |
CN1278727C (zh) | 一种结肠炎灌肠剂 | |
CN1167453C (zh) | 一种治疗痔疮的散剂 | |
CN106728069B (zh) | 一种治疗烫烧伤的祛腐生肌膏 | |
CN1058634C (zh) | 植物留兰香作为制备治痔疮病药的应用 | |
CN1238012C (zh) | 一种治疗牙痛、口腔疾病的药物 | |
CN1103791A (zh) | 烧烫伤喷洒药物及其制备工艺 | |
CN1229651A (zh) | 痔疮散 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |